| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP1094812A1 Angiogenesis inhibitors |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0946097B1 Composition and use |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293082A Alkylated ammonia alkyl cyclic urea surface active agent |
| 05/02/2001 | CN1065112C Insecticidal composition comprising benzohydroximoylazole derivatives |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225023 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028979A2 Inhibitors of neuraminidases |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/25/2001 | CN1064813C Methylolhydantoins compositions |
| 04/24/2001 | US6222046 As trifluoroacetoxylation agent |
| 04/24/2001 | US6222039 Reacting lactone compound containing nitrogen heterocycle with cyclic amine; oxidizing to form carboxylic acid group; introducing hydroxylamine group at hydroxyl of carboxylic acid group |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221907 Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same |
| 04/24/2001 | US6221898 Anticoagulants |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | CA2046397C Inflammatory bowel disease preventive and curative agents containing zinc l- carnosine salt or complex as active ingredient |
| 04/19/2001 | WO2001027122A1 Pre-cursor for radiodiagnostic agents and the production thereof |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027087A2 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026629A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026625A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026467A1 Methods of enhancing chemotherapy |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2382727A1 Methods of enhancing chemotherapy with the use of an imidazole |
| 04/18/2001 | EP1092712A1 Process for preparing fungicidal oxazolidinones and imidazolinones |
| 04/18/2001 | EP1092711A1 Retinoid-associated receptor regulators |
| 04/18/2001 | EP1092710A1 Alkylated aminoalkyl cyclic urea surfactants |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | CN1291982A Nitrate salt of anti-ulcer medicine |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/17/2001 | US6218549 Bicyclic aminoimidazoles |
| 04/17/2001 | US6218544 Heterocyclic esters and amides |
| 04/17/2001 | US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain. |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025229A1 Amide compounds |
| 04/12/2001 | WO2001025216A1 1-aryl-1,3-dihydro-imidazol-2-(thi)one derivatives, production of said compound and use as a dessicating/defoliating agent for plants |
| 04/12/2001 | WO2001025215A2 Method for selectively dissociating cyclic carboxylic acid anhydrides |
| 04/12/2001 | WO2001025214A1 Method of producing low-odor imidazolines, imidazolines produced thereby and paper and paper products containing the same |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001025170A1 N-SUBSTITUTED DIALKYL α-AMINO ACIDS FOR USE AS AMINO PROTECTING GROUPS |
| 04/12/2001 | WO2001024798A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 04/12/2001 | WO2000049031A3 Method for isolating nucleic acids |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | US20010000259 Curing agent, catalyst, accelerator of a derivative of 1-(hydrocarbyloxycarbonyl)imidazole; latency at room temperature; high activity upon heating; molding materials; coatings; bonding; lamination; foams; electrical devices |
| 04/12/2001 | DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke |
| 04/12/2001 | DE19947953A1 Verfahren zur selektiven Spaltung cyclischer Carbonsäureanhydride Process for the selective cleavage of cyclic anhydrides |
| 04/12/2001 | CA2387706A1 1-aryl-1,3-dihydro-imidazol-2-(thi)one derivatives, production of said compound and use as a dessicating/defoliating agent for plants |
| 04/12/2001 | CA2386157A1 Amide compounds |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090909A1 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 04/11/2001 | EP1089978A1 Process for preparing oximidazoles |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1068192A4 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 04/11/2001 | CN1291216A Azo comounds and process for producing the same |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/10/2001 | US6215001 Imidazole derivatives as therapeutic agents |
| 04/10/2001 | US6215000 Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol |
| 04/10/2001 | US6214995 Synthetic polymer stabilized against thermal and photo deterioration with a 7,7,9,9-tetramethyl-1,3,8-triazaspiro(4,5)decan-2,4-dione derivative of given formula |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214834 Angiogenesis inhibitors; antiinflammatory agents; anticancer agents |
| 04/10/2001 | CA2032593C 2-(1-substituted-2-imidazolin-2-yl)benzoic and nicotinic acids and a method for their preparation |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 04/05/2001 | WO2000051547A3 Inhibitors of prenyl-protein transferase |
| 04/05/2001 | DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter |
| 04/04/2001 | EP1089305A2 Electrolyte composition, photoelectric conversion device and photo-electrochemical cell |
| 04/04/2001 | EP1087945A1 Method for producing carbonyldiimidazole |
| 04/04/2001 | EP1087944A1 Procedure for producing formyl imidazoles |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | EP0912465B1 Improved lithium and amine dissolving metal reduction |
| 04/04/2001 | EP0738263B1 Substituted phenylimidazolidines having antiandrogen activity |
| 04/04/2001 | EP0630888B1 Imidazoline derivative, production thereof, and blood pressure retentive |
| 04/04/2001 | CN1290252A Method for producing heteroaromatic aldehydes |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1289766A Penicillene compounds and derivatives therefrom |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |